Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER

Perkovic V, Bain SC, Bakris G, Buse JB, Gondolf T, Idorn T, Lausvig N, Mahaffey K, Marso SP, Nauck MA, Pratley R, Rossing P, Zinman B, Mann J (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Diabetologia Springer Verlag (Germany)

Publisher: SPRINGER

City/Town: NEW YORK

Pages Range: S484-S485

Conference Proceedings Title: DIABETOLOGIA

Event location: Barcelona ES

DOI: 10.1093/ndt/gfz106.fp482

Involved external institutions

Ruhr-Universität Bochum (RUB) DE Germany (DE) Novo Nordisk A/S DK Denmark (DK) Stanford Medicine US United States (USA) (US) University of Toronto CA Canada (CA) University of New South Wales (UNSW) AU Australia (AU) AdventHealth US United States (USA) (US) Steno Diabetes Center DK Denmark (DK) University of Chicago Medical Center US United States (USA) (US) Swansea University GB United Kingdom (GB) University of North Carolina at Chapel Hill US United States (USA) (US)

How to cite

APA:

Perkovic, V., Bain, S.C., Bakris, G., Buse, J.B., Gondolf, T., Idorn, T.,... Mann, J. (2019). Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER. In DIABETOLOGIA (pp. S484-S485). Barcelona, ES: NEW YORK: SPRINGER.

MLA:

Perkovic, V., et al. "Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER." Proceedings of the 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona NEW YORK: SPRINGER, 2019. S484-S485.

BibTeX: Download